Are you Dr. Elfiky?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 76 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
20 York St
New Haven, CT 06510Phone+1 203-688-4242Fax+1 617-632-2165
Summary
- Dr. Aymen Elfiky, MD is an oncologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut, New York, and Florida. He is affiliated with Brooklyn Hospital Center and is an Instructor at Harvard Medical School; Instructor.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
NYU Grossman School of MedicineResidency, Internal Medicine, 2003 - 2005- Yale-New Haven Medical CenterInternship, Internal Medicine, 2001 - 2002
Washington University in St. Louis School of MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2018 - 2026
CT State Medical License 2024 - 2025
MA State Medical License 2008 - 2025
FL State Medical License 2015 - 2017
Clinical Trials
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- 1 citationsClinical Evidence for the Benefits of Neoadjuvant Chemotherapy and Immunotherapy in Colon Cancer: A Concise Review.Kush Gupta, Aymen Elfiky, Eshan Patel
Discovery Medicine. 2023-12-01 - 2 citationsRace, Biology, Disparities, and Prostate Cancer.Andrew J Vickers, Aymen Elfiky, Vincent L Freeman, Mack Roach 3rd
European Urology. 2022-05-01 - 5 citationsNovel findings from determination of common expressed plasma exosomal microRNAs in patients with psoriatic arthritis, psoriasis vulgaris, rheumatoid arthritis, and gou...Ashish Gupta, Aymen Elfiky
Discovery Medicine. 2019-08-01
Authored Content
- Development and Application of a Machine Learning Approach to Assess Short-Term Mortality Risk Among Patients with Cancer Starting ChemotherapyJuly 2018
Press Mentions
Algorithms ‘Highly Accurate’ Using EHRs to Predict Mortality for Chemo PatientsJuly 31st, 2018
User:AymenelfikyMarch 30th, 2018
